Swiss National Bank’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,600
| Closed | -$788K | – | 2528 |
|
|
2024
Q1 | $788K | Hold |
18,600
| – | – | ﹤0.01% | 2331 |
|
|
2023
Q4 | $777K | Sell |
18,600
-2,300
| -11% | -$96.1K | ﹤0.01% | 2367 |
|
|
2023
Q3 | $788K | Hold |
20,900
| – | – | ﹤0.01% | 2370 |
|
|
2023
Q2 | $793K | Buy |
20,900
+400
| +2% | +$15.2K | ﹤0.01% | 2411 |
|
|
2023
Q1 | $499K | Sell |
20,500
-2,000
| -9% | -$48.6K | ﹤0.01% | 2521 |
|
|
2022
Q4 | $653K | Hold |
22,500
| – | – | ﹤0.01% | 2508 |
|
|
2022
Q3 | $675K | Hold |
22,500
| – | – | ﹤0.01% | 2478 |
|
|
2022
Q2 | $814K | Buy |
22,500
+200
| +0.9% | +$7.24K | ﹤0.01% | 2468 |
|
|
2022
Q1 | $965K | Buy |
22,300
+1,400
| +7% | +$60.6K | ﹤0.01% | 2424 |
|
|
2021
Q4 | $1.05M | Sell |
20,900
-300
| -1% | -$15K | ﹤0.01% | 2454 |
|
|
2021
Q3 | $1.35M | Hold |
21,200
| – | – | ﹤0.01% | 2284 |
|
|
2021
Q2 | $1.53M | Sell |
21,200
-600
| -3% | -$43.2K | ﹤0.01% | 2268 |
|
|
2021
Q1 | $1.61M | Hold |
21,800
| – | – | ﹤0.01% | 2135 |
|
|
2020
Q4 | $1.6M | Buy |
+21,800
| New | +$1.6M | ﹤0.01% | 2035 |
|
|
2017
Q4 | – | Sell |
-47,100
| Closed | -$5.31M | – | 2538 |
|
|
2017
Q3 | $5.31M | Buy |
47,100
+600
| +1% | +$67.6K | 0.01% | 981 |
|
|
2017
Q2 | $5.21M | Sell |
46,500
-6,700
| -13% | -$751K | 0.01% | 968 |
|
|
2017
Q1 | $6.2M | Sell |
53,200
-3,800
| -7% | -$443K | 0.01% | 861 |
|
|
2016
Q4 | $6M | Sell |
57,000
-70,200
| -55% | -$7.39M | 0.01% | 850 |
|
|
2016
Q3 | $14.1M | Sell |
127,200
-1,700
| -1% | -$188K | 0.02% | 585 |
|
|
2016
Q2 | $18.8M | Buy |
128,900
+97,700
| +313% | +$14.2M | 0.03% | 530 |
|
|
2016
Q1 | $4.28M | Buy |
31,200
+1,700
| +6% | +$233K | 0.01% | 965 |
|
|
2015
Q4 | $4.56M | Buy |
+29,500
| New | +$4.56M | 0.01% | 831 |
|